BlackRock Fund Advisors’s ProPhase Labs PRPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$10K Buy
491
+108
+28% +$2.18K ﹤0.01% 3967
2016
Q3
$8K Buy
383
+40
+12% +$687 ﹤0.01% 3998
2016
Q2
$4K Buy
343
+26
+8% +$350 ﹤0.01% 4129
2016
Q1
$4K Buy
317
+61
+24% +$764 ﹤0.01% 4128
2015
Q4
$4K Buy
+256
New +$3.71K ﹤0.01% 4178

Other funds holding PRPH

BlackRock Fund Advisors's PRPH Position: Q4 2016 in Review

BlackRock Fund Advisors increased its ProPhase Labs (PRPH) stake by 28% in Q4 2016, buying an estimated $2.18K and bringing the position to 491 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #3967.

BlackRock Fund Advisors first reported a position in PRPH in Q4 2015 and has held it in 5 quarters since. 13 funds tracked by Wall St. Rank hold PRPH as of Q4 2016.

  • BlackRock Fund Advisors held 491 shares of ProPhase Labs worth $10K as of Q4 2016.
  • BlackRock Fund Advisors bought 108 ProPhase Labs shares in Q4 2016, an estimated $2.18K.
  • ProPhase Labs made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3967 holding.
  • BlackRock Fund Advisors first reported a position in ProPhase Labs in Q4 2015 and has held it in 5 quarters since.
  • 13 funds tracked by Wall St. Rank held ProPhase Labs as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.